Participants 86 141 4
Japanese women with bone metastases from breast cancer:
Participants 306 499 7
PATIENTS AND METHODS Women with bone metastases (N = 228) were randomly assigned to receive 4 mg zoledronic acid (n = 114) or placebo (n = 114) via 15-minute infusions every 4 weeks for 1 year.
